Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: Considerations for different sensors

Diabetes Technology and Therapeutics

Volumn 16, Issue 5, 2014, Pages 326-327

  Mitre, Tina Maria ^a   Legault, Laurent ^b   Rabasa Lhoret, Rémi ^a,c,d   Haidar, Ahmad ^a,e  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Montreal Diabetes Research Center   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; INSULIN;

BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; LETTER; MONITOR; PATIENT ASSESSMENT; PRIORITY JOURNAL; AMBULATORY MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PROCEDURES; INSULIN INFUSION; MALE; PROCEDURES;

BIOSENSING TECHNIQUES; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY;

EID: 84899086714     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0286     Document Type: Letter

References (4)

1. Hovorka R, Nodale M, Haidar A, Wilinska ME: Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: Drawbacks and way forward. Diabetes Technol Ther 2013;15:4-12.
2. Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R: Glucose-responsive insulin and glucagon delivery (dualhormone artificial pancreas) in adults with type 1 diabetes: A randomized crossover controlled trial. CMAJ 2013;185: 297-305.
3. Calhoun P, Lum J, Beck RW, Kollman C: Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013;15:758-761.
4. Beck RW, Calhoun P, Kollman C: Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther 2012;14:877-882.